SONOMA PHARMACEUTICALS, INC. Proceeds from Long-term Capital Lease Obligations
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Proceeds from Long-term Capital Lease Obligations of -$324.00 thousand for the 12-month period ending 2019-03-31, per its 10-K filed 2019-07-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLongTermCapitalLeaseObligations · last filed 2019-07-01
- SONOMA PHARMACEUTICALS, INC. proceeds from long-term capital lease obligations for the quarter ending 2019-03-31 was -$215.00K.
- SONOMA PHARMACEUTICALS, INC. proceeds from long-term capital lease obligations for the quarter ending 2018-12-31 was -$37.00K.
- SONOMA PHARMACEUTICALS, INC. proceeds from long-term capital lease obligations for the quarter ending 2018-09-30 was -$37.00K.
- SONOMA PHARMACEUTICALS, INC. proceeds from long-term capital lease obligations for the quarter ending 2018-06-30 was -$35.00K.
- SONOMA PHARMACEUTICALS, INC. proceeds from long-term capital lease obligations for fiscal 2019 was -$324.00K.
- SONOMA PHARMACEUTICALS, INC. proceeds from long-term capital lease obligations for fiscal 2018 was -$132.00K.
| Period end | Proceeds from Long-term Capital Lease Obligations 3 month | Proceeds from Long-term Capital Lease Obligations 6 month | Proceeds from Long-term Capital Lease Obligations 9 month | Proceeds from Long-term Capital Lease Obligations 12 month |
|---|---|---|---|---|
| 2019-03-31 | -$215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-01 | -$252.00K derived: sum of 2 quarters · filed 2019-07-01 | -$289.00K derived: sum of 3 quarters · filed 2019-07-01 | -$324.00K 10-K · filed 2019-07-01 |
| 2018-12-31 | -$37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-14 | -$74.00K derived: sum of 2 quarters · filed 2019-02-14 | -$109.00K 10-Q · filed 2019-02-14 | -$144.00K derived: sum of 4 quarters · filed 2019-07-01 |
| 2018-09-30 | -$37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-08 | -$72.00K 10-Q · filed 2018-11-08 | -$107.00K derived: sum of 3 quarters · filed 2019-07-01 | -$140.00K derived: sum of 4 quarters · filed 2019-07-01 |
| 2018-06-30 | -$35.00K 10-Q · filed 2018-08-08 | -$70.00K derived: sum of 2 quarters · filed 2019-07-01 | -$103.00K derived: sum of 3 quarters · filed 2019-07-01 | -$136.00K derived: sum of 4 quarters · filed 2019-07-01 |
| 2018-03-31 | -$35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-01 | -$68.00K derived: sum of 2 quarters · filed 2019-07-01 | -$101.00K derived: sum of 3 quarters · filed 2019-07-01 | -$132.00K 10-K · filed 2019-07-01 |
| 2017-12-31 | -$33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-14 | -$66.00K derived: sum of 2 quarters · filed 2019-02-14 | -$97.00K 10-Q · filed 2019-02-14 | |
| 2017-09-30 | -$33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-08 | -$64.00K 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | -$31.00K 10-Q · filed 2018-08-08 | |||
| 2016-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-14 | $0.00 derived: sum of 2 quarters · filed 2018-02-14 | $0.00 10-Q · filed 2018-02-14 | |
| 2016-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-14 | $0.00 10-Q · filed 2017-11-14 | ||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |